Mahsa Salsabili, PharmD, PhD, presents an overview of prescription digital therapeutics and their application in addressing unmet patient needs across various disease states, including diabetes, addiction, and mental health conditions.
FDA Expands Akili's EndeavorRx Game-Based Digital Therapy for ADHD Eligibility to Ages 8-17
December 21st 2023As the only FDA-approved, game-based digital therapeutic, EndeavorRx’s eligibility is expected to more than double the number of pediatric patients with ADHD who have a prescription from a healthcare provider, due to the increased age range.
Read More